Physician profile
Andrew Saltzman
NPI 1053318865
$9,197.21
in general payments reported to CMS, 2019-2025
20 companies · $215 in 2025
The $215 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,732 · 2020: $270 · 2021: $1,510 · 2022: $1,191 · 2023: $232 · 2024: $47.52 · 2025: $215.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $344 · Education: $151.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $343.59 |
| Education | $150.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,287.83 | 2019-2022 | |
| Alpha Orthopedic Systems | $2,233.12 | 2019-2020 | |
| Arthrex, INC. | $1,956.50 | 2019 | |
| Medical Device Business Services, INC. | $1,168.12 | 2021 | |
| Horizon Therapeutics Plc | $488.37 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $386.90 | 2022-2023 | Comprehensive Shoulder System |
| Depuy Synthes Sales INC. | $200.37 | 2021-2025 | Dynacord, Dynatape, Twistr |
| Sanofi-Aventis U.S. LLC | $90.11 | 2019-2023 | |
| Pacira Therapeutics, INC. | $77.69 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $57.01 | 2025 | |
| Ethicon US, LLC | $55.12 | 2025 | Stratafix, Vistaseal, Dermabond Prineo |
| Ferring Pharmaceuticals INC. | $48.91 | 2019-2025 | Euflexxa |
| Pacira Pharmaceuticals Incorporated | $34.12 | 2023-2025 | Iovera, Exparel, Zilretta |
| Innovation Technologies INC | $24.16 | 2025 | Irrisept |
| Orthogenrx INC. | $19.03 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Crossroads Orthopedics, LLC | $17.28 | 2024 | |
| Orthofix Medical, INC. | $14.96 | 2019 | |
| Convatec INC. | $13.58 | 2020 | |
| Endo Pharmaceuticals INC. | $12.92 | 2019 | |
| Fidia Pharma USA INC. | $11.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Saltzman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.